IPG-0916

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameIPG-0916
Drug Alias NameIPG-0916IPG0916
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of Actionanti-C-C chemokine receptor type 6
TargetsC-C chemokine receptor type 6
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesImmunophage Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunophage Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A